Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24266403)

1.

Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions.

Aiba Y, Hu J, Liu J, Xiang Q, Martinez C, Corey DR.

Biochemistry. 2013 Dec 23;52(51):9329-38. doi: 10.1021/bi4014209. Epub 2013 Nov 27.

2.

RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression.

Liu J, Pendergraff H, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Hu J, Corey DR.

Nucleic Acids Res. 2013 Oct;41(18):8788-801. doi: 10.1093/nar/gkt594. Epub 2013 Jul 24.

3.

Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.

Hu J, Liu J, Narayanannair KJ, Lackey JG, Kuchimanchi S, Rajeev KG, Manoharan M, Swayze EE, Lima WF, Prakash TP, Xiang Q, Martinez C, Corey DR.

Biochemistry. 2014 Jul 22;53(28):4510-8. doi: 10.1021/bi500610r. Epub 2014 Jul 11.

4.

Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.

Hu J, Liu J, Corey DR.

Chem Biol. 2010 Nov 24;17(11):1183-8. doi: 10.1016/j.chembiol.2010.10.013.

5.

Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.

Hu J, Liu J, Yu D, Chu Y, Corey DR.

Nucleic Acids Res. 2012 Dec;40(22):11270-80. doi: 10.1093/nar/gks907. Epub 2012 Oct 4.

6.

ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.

Liu J, Yu D, Aiba Y, Pendergraff H, Swayze EE, Lima WF, Hu J, Prakash TP, Corey DR.

Nucleic Acids Res. 2013 Nov;41(20):9570-83. doi: 10.1093/nar/gkt693. Epub 2013 Aug 9.

7.

Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.

Hu J, Liu J, Yu D, Aiba Y, Lee S, Pendergraff H, Boubaker J, Artates JW, Lagier-Tourenne C, Lima WF, Swayze EE, Prakash TP, Corey DR.

Nucleic Acid Ther. 2014 Jun;24(3):199-209. doi: 10.1089/nat.2013.0476. Epub 2014 Apr 2.

8.

An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.

Fiszer A, Olejniczak M, Switonski PM, Wroblewska JP, Wisniewska-Kruk J, Mykowska A, Krzyzosiak WJ.

BMC Mol Biol. 2012 Mar 7;13:6. doi: 10.1186/1471-2199-13-6.

9.

Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA.

Hu J, Matsui M, Corey DR.

Ann N Y Acad Sci. 2009 Sep;1175:24-31. doi: 10.1111/j.1749-6632.2009.04975.x.

10.

Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.

Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H.

PLoS One. 2008 May 21;3(5):e2248. doi: 10.1371/journal.pone.0002248.

11.

Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats.

Fiszer A, Mykowska A, Krzyzosiak WJ.

Nucleic Acids Res. 2011 Jul;39(13):5578-85. doi: 10.1093/nar/gkr156. Epub 2011 Mar 22.

12.

Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.

Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR.

Nat Biotechnol. 2009 May;27(5):478-84. doi: 10.1038/nbt.1539. Epub 2009 May 3.

13.

Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAs.

Hu J, Gagnon KT, Liu J, Watts JK, Syeda-Nawaz J, Bennett CF, Swayze EE, Randolph J, Chattopadhyaya J, Corey DR.

Biol Chem. 2011 Apr;392(4):315-25. doi: 10.1515/BC.2011.045. Epub 2011 Feb 7.

14.

Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.

Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF, Montaillier C, Lemaitre M, Corey DR.

Biochemistry. 2010 Nov 30;49(47):10166-78. doi: 10.1021/bi101208k. Epub 2010 Nov 8.

15.

Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.

Li F, Pallan PS, Maier MA, Rajeev KG, Mathieu SL, Kreutz C, Fan Y, Sanghvi J, Micura R, Rozners E, Manoharan M, Egli M.

Nucleic Acids Res. 2007;35(19):6424-38. Epub 2007 Sep 18.

16.

Unlocked nucleic acid--an RNA modification with broad potential.

Pasternak A, Wengel J.

Org Biomol Chem. 2011 May 21;9(10):3591-7. doi: 10.1039/c0ob01085e. Epub 2011 Mar 23. Review.

PMID:
21431171
17.

Bis-pyrene-modified unlocked nucleic acids: synthesis, hybridization studies, and fluorescent properties.

Perlíková P, Ejlersen M, Langkjaer N, Wengel J.

ChemMedChem. 2014 Sep;9(9):2120-7. doi: 10.1002/cmdc.201402185. Epub 2014 Jul 18.

PMID:
25044312
18.

Sequence-dependent and independent inhibition specific for mutant ataxin-3 by small interfering RNA.

Li Y, Yokota T, Matsumura R, Taira K, Mizusawa H.

Ann Neurol. 2004 Jul;56(1):124-9.

PMID:
15236410
19.

Thermodynamics of RNA duplexes modified with unlocked nucleic acid nucleotides.

Pasternak A, Wengel J.

Nucleic Acids Res. 2010 Oct;38(19):6697-706. doi: 10.1093/nar/gkq561. Epub 2010 Jun 18.

20.

Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.

Fiszer A, Olejniczak M, Galka-Marciniak P, Mykowska A, Krzyzosiak WJ.

Nucleic Acids Res. 2013 Dec;41(22):10426-37. doi: 10.1093/nar/gkt825. Epub 2013 Sep 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk